Biotech grants in the United States

Between cycles

Funds preclinical or animal arthritis research that's too applied to count as basic science and not yet ready for people.

Between cycles

Funds a clinical trial of a new autism treatment, product or device, from a small proof-of-concept study up to a full efficacy trial.

Between cycles

Funds breast cancer research mature enough to run a small clinical trial, though a trial is not required at this level.

Between cycles

Funds a single, large breast cancer research effort built around a clinical trial that has to happen.

Between cycles

Funds a large, multi-institution team of scientists, clinicians and advocates tackling one breast cancer problem too big for a single lab.

Between cycles

Funds preclinical or clinical Duchenne muscular dystrophy research, at a smaller or a larger funding level.

Between cycles

Funds an early-stage idea in Duchenne muscular dystrophy research, without requiring a clinical trial.

Between cycles

Funds drug discovery and therapy development for hearing loss from military-relevant injury, not tinnitus or balance disorders.

Between cycles

Funds an early-career researcher's kidney cancer project alongside paired mentoring inside the program's own investigator academy.

Between cycles

Funds an early-stage kidney cancer research idea built on a clear hypothesis and a strong scientific rationale.

Between cycles

Funds an early-stage, high-risk lung cancer research idea, with a separate track for investigators new to independent research.

Between cycles

Funds translational lung cancer research moving toward the clinic, at either a late preclinical stage or a pilot clinical trial.

Between cycles

Funds a multi-investigator research program tackling one shared question in rare melanoma, split across two or three linked projects.

Between cycles

Funds an exploratory, high-risk melanoma research idea, where existing preliminary data is discouraged rather than expected.

Between cycles

Funds an early-career melanoma researcher's project alongside guided mentoring inside the program's own academy.

Between cycles

Funds a multi-investigator melanoma research team through a pre-application screen, with each partner named on their own award.

Between cycles

Funds early, untested ideas in combat-relevant burn care meant to generate the preliminary data a later study would need.

Between cycles

Funds turning preclinical burn-care findings into an actual product — a device, a drug, or a clinical practice guideline.

Between cycles

Funds the earliest, most speculative stage of a neurofibromatosis idea, before any preliminary data exists.

Between cycles

Funds established neurofibromatosis research addressing a critical need, with an optional level adding collaboration or open data sharing.

Between cycles

Funds an early-career investigator's neurofibromatosis project inside a mentored research academy, guided by a designated Career Guide.

Between cycles

Funds 2 to 3 investigators jointly pursuing one new idea in neurofibromatosis, with each partner named on a separate award.

Between cycles

Funds clinical trials of ovarian cancer drugs, biologics, devices or guidance, from small pilots to large efficacy studies.

Between cycles

Funds a small, patient-centred pilot in pancreatic cancer research, meant to produce the preliminary data a bigger study would need.